Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a

Cover Page

Cite item

Abstract

Anthrax is a particularly dangerous infectious disease that affects humans and livestock. It is characterized by intoxication, serosanguineous skin lesions, development of lymph nodes and internal organs, and may manifest itsself in either a cutaneous or septic form. The pathogenic agent is Bacillus anthracis, a grampositive, endospore-forming, rod-shaped aerobic bacterium. Efficacious vaccines that can rapidly induce a long-term immune response are required to prevent anthrax infection in humans. In this study, we designed three recombinant human adenovirus serotype-5-based vectors containing various modifications of the fourth domain of the B. anthracis protective antigen (PA). Three PA modifications were constructed: a secretable form (Ad-sPA), a non-secretable form (Ad-cPA), and a form with the protective antigen fused to the Fc fragment of immunoglobulin G2a (Ad-PA-Fc). All these forms exhibited protective properties against Bacillus anthracis. The highest level of protection was induced by the Ad-PA-Fc recombinant adenovirus. Our findings indicate that the introduction of the Fc antibody fragment into the protective antigen significantly improves the protective properties of the Ad-PA-Fc adenovirus against B. anthracis.

About the authors

D. N. Shcherbinin

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Author for correspondence.
Email: dim284@inbox.ru
Russian Federation

I. B. Esmagambetov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Russian Federation

A. N. Noskov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Russian Federation

Yu. O. Selyaninov

National Research Institute for Veterinary Virology and Microbiology of Russia

Email: dim284@inbox.ru
Russian Federation

I. L. Tutykhina

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Russian Federation

M. M. Shmarov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Russian Federation

D. Yu. Logunov

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Russian Federation

B. S. Naroditskiy

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Russian Federation

A. L. Gintsburg

Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Public Health of the Russian Federation

Email: dim284@inbox.ru
Russian Federation

References

  1. Guichard A., Nizet V., Bier E. // Microbes Infect. 2012. V. 14. № 2. P. 97-118.
  2. Brachman P.S. // Ann. N.Y. Acad. Sci. 1980. № 353. P. 83-93.
  3. Davies J.C.A. // Central African J. Med. 1982. № 28. P. 291-298.
  4. Davies J.C.A. // Central African J. Med. 1983. № 29. P. 8-12.
  5. Davies J.C.A. // Central African J. Med. 1985. № 31. P. 176-180.
  6. Metcalfe N. // Occup. Med. 2004. V. 54. № 7. P. 489-493.
  7. Meaney-Delman D., Zotti M.E., Rasmussen S.A., Strasser S., Shadomy S., Turcios-Ruiz R.M., Wendel G.D., Treadwell T.A., Jamieson D.J., Gladus M.A., et al. // Obstet. Gynecol. Dec. 2012. V. 120. № 6. P. 1439-1449.
  8. Ipatenko N.G., Gavrilov V.A., Manichev A.A., Bastarov S.I., Salenko L.S., Yakovleva T.N., Stepanova V.V., Shmorgun B.I., Kiselev Yu.T., Sayitkhulov B.S. // Veterinary. 1995. № 5. С. 27-30.
  9. Auerbach S., Wright G.G. // J. Immunol. 1955. V. 75. № 2. P. 129-133.
  10. Broster M.G., Hibbs S.E. // Salisbury Med. Bull. Sp. Suppl. 1990. № 68. P. 91-92.
  11. Little S.F., Knudson G.B., Neidhardt F.C. // Ann. Meet. Amer. Soc. Microbiol. 1984. P. 46.
  12. Ward M.K., McGann V.G., Hogge A.L., Huff M.L., Kanode R.G., Roberts E.O. // J. Infect. Dis. 1965. № 115. P. 59-67.
  13. McConnell M.J., Hanna P.C., Imperiale M.J. // Infect. Immun. 2006. V. 74. № 2. P. 1009-1015.
  14. Tan Y., Hackett N.R., Boyer J.L., Crystal R.G. // Hum. Gene. Ther. 2003. V. 14. № 17. P. 1673-1682.
  15. Hashimoto M., Boyer J.L., Hackett N.R., Wilson J.M., Crystal R.G. // Infect. Immun. 2005. V. 73. № 10. P. 6885-6891.
  16. Yu Y.Z., Li N., Wang W.B., Wang S., Ma Y., Yu W.Y., Sun Z.W. // Vaccine. 2010. V. 28. № 47. P. 7529-7535.
  17. McConnell M.J., Hanna P.C., Imperiale M.J. // Mol. Ther. 2007. V. 15. № 1. P. 203-210.
  18. Shcherbinin D. N., Shmarov M.M., Naroditsky B.S., Rubakova E.I., Kondrateva T.K. // Tubercullosis and lung diseases. 2010. V. 87. № 10. P. 50-53.
  19. Shcherbinin D. N., Tutyhina I.L., Logunov D.U.,Shmarov M.M., Apt A.S., Kondrateva T.K. Naroditsky B.S. //Med. immunol. 2010. V. 13. № 4-5. P. 347.
  20. Sigalov A.B. // Adv. Exp. Med. Biol. 2008. № 640. P. 121-163.
  21. Graham D.B., Akilesh H.M., Gmyrek G.B., Piccio L., Gilfillan S., Sim J., Belizaire R., Carrero J.A., Wang Y., Blaufuss G.S., et al. // Blood. 2010. V. 116. № 17. P. 3208-3218.
  22. Walport M.J. // N. Engl. J. Med. 2001. V. 344. № 14. P. 1058-1066.
  23. Tutykhina I.L., Logunov D.Y., Shcherbinin D.N., Shmarov M.M., Tukhvatulin A.I., Naroditsky B.S., Gintsburg A.L. // J. Mol. Med. 2011. V. 89. № 4. P. 331-341.
  24. Zhang J., Jex E., Feng T., Sivko G.S., Baillie L.W., Goldman S., van Kampen K.R., Tang D.C. // Clin. Vaccine Immunol. 2013. V. 20. № 1. P. 1-8.
  25. Radjainia M., Hyun J.K., Leysath C.E., Leppla S.H., Mitra A.K. // Proc. Natl. Acad. Sci. USA. 2010. V. 107. № 32. P. 14070-14074.

Copyright (c) 2014 Shcherbinin D.N., Esmagambetov I.B., Noskov A.N., Selyaninov Y.O., Tutykhina I.L., Shmarov M.M., Logunov D.Y., Naroditskiy B.S., Gintsburg A.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies